ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,618.26
-0.29%
US Tech 100
18,927.60
-0.06%
Dow Jones
41,503.10
-0.25%
Brent Oil
72.735
0.49%
Bitcoin
61,904.20
0.39%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Anebulo Pharmaceuticals Inc (ANEB) Quote

Anebulo Pharmaceuticals Inc

Anebulo Pharmaceuticals Inc (ANEB)

NASDAQ
2.00
-0.27
(-11.89%)
Closed September 18 4:00PM
Delayed by 15 minutes
2.16
0.16
(8.00%)
After Hours: 7:59PM
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
2.00
Bid
2.08
Ask
2.28
Volume
4,467
2.15 Day's Range 2.32
1.62 52 Week Range 3.71
Market Cap
51.866M
Previous Close
2.27
Open
2.30
Last Trade
60
@
2.2
Last Trade Time
Financial Volume
$ 9,947
VWAP
2.2268
Average Volume (3m)
3,658
Shares Outstanding
25,933,217
Dividend Yield
-
PE Ratio
-4.77
Earnings Per Share (EPS)
-0.45
Revenue
-
Net Profit
-11.73M

About Anebulo Pharmaceuticals Inc

Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company. It is developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of admini... Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company. It is developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.anebulo.com
Headquarters
Dover, Delaware, USA
Founded
-
Anebulo Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ANEB. The last closing price for Anebulo Pharmaceuticals was $2.27. Over the last year, Anebulo Pharmaceuticals shares have traded in a share price range of $ 1.62 to $ 3.71.

Anebulo Pharmaceuticals currently has 25,933,217 shares outstanding. The market capitalization of Anebulo Pharmaceuticals is $58.87 million. Anebulo Pharmaceuticals has a price to earnings ratio (PE ratio) of -4.77.

Ask ADVFN Intelligence (AI)

ANEB Latest News

More News

Form 8-K - Current report

July 22 2024
Edgar (US Regulatory)

Anebulo Pharmaceuticals Awarded NIDA Grant for its Investigational IV Treatment for Acute Cannabis-Induced Toxic Effects

Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabis-induced toxic effects (the “Company”...

July 22 2024
Business Wire

Lifecore Biomedical Announces Cooperation Agreement with 22NW

CHASKA, Minn., July 01, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization...

July 01 2024
GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities

June 17 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

June 17 2024
Edgar (US Regulatory)

Form 8-K - Current report

June 17 2024
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

May 15 2024
Edgar (US Regulatory)

Form 8-K - Current report

May 15 2024
Edgar (US Regulatory)

Anebulo Pharmaceuticals Reports Third Quarter Fiscal Year 2024 Financial Results and Recent Updates

Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid toxicities that include acute...

May 15 2024
Business Wire

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

February 13 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.2413.63636363641.762.31.7238031.96674766CS
40.136.951871657751.872.31.7241431.90121481CS
12-0.68-25.37313432842.682.961.7236582.16594766CS
26-0.41-17.01244813282.413.31.7254012.47017945CS
52-1.71-46.09164420493.713.711.6296552.42029561CS
156-4.91-71.05643994216.917.8851.6281433.43797478CS
260-5.38-72.89972899737.389.331.6299064.4745852CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
OMEXOdyssey Marine Exploration Inc
$ 1.39
(180.07%)
324.51M
PRTGPortage Biotech Inc
$ 9.91
(118.76%)
49.9M
APLTApplied Therapeutics Inc
$ 7.85
(68.82%)
49.49M
XCHXCHG Ltd
$ 18.39
(65.68%)
1.26M
WBUYWeBuy Global Ltd
$ 0.18675
(60.99%)
228.66M
GLMDGalmed Pharmaceuticals Ltd
$ 6.8501
(-54.64%)
5.79M
KAKineta Inc
$ 0.5691
(-31.35%)
530.66k
DTSSDatasea Inc
$ 2.07
(-29.59%)
1.28M
CBUSCibus Inc
$ 3.595
(-28.95%)
2.25M
BFIBurgerFi International Inc
$ 0.1705
(-26.98%)
16.23M
OMEXOdyssey Marine Exploration Inc
$ 1.39
(180.07%)
328.97M
NVDANVIDIA Corporation
$ 113.37
(-1.92%)
310.35M
WBUYWeBuy Global Ltd
$ 0.1867
(60.95%)
248.03M
SQQQProShares UltraPro Short QQQ
$ 8.40
(1.45%)
200.73M
LUNRIntuitive Machines Inc
$ 7.4512
(37.99%)
141.86M

Discussion

View Full Feed
NASDAQ2020 NASDAQ2020 2 minutes ago
https://www.cbsnews.com/news/fda-approves-generic-oxycontin/
ELTP
blackhawks blackhawks 2 minutes ago
They HAVE to, by law, communicate the indication(s). Usually it's spoken, but easy to miss. It also appears on the screen like those brief 'with diet and exercise' pro forma for Jardiance. But unless it's about your malady who pays that much attention?
ChannelTrader ChannelTrader 2 minutes ago
Gutfeld live ... https://lakestreams.com/fox-news/
familyof5 familyof5 2 minutes ago
Just having a little fun poking the bear lol. We all know some of these close’s should have been greener!.....
RDGL
Cake Eater Cake Eater 5 minutes ago
Accord Healthcare filed an Abbreviated New Drug Application (ANDA) No. 213564 for approval to market a generic version of OxyContin. The exact date of filing is not specified, but it occurred sometime prior to October 2020, as evidenced by the lawsuit filed by Purdue Pharma against Accord Healthcare
ELTP
Viking61 Viking61 5 minutes ago
More and more will be failing with the amount of illegals in the US. Look at Arizona.
FNMA
Reluctant Observer Reluctant Observer 5 minutes ago
Gillian’s XRP?
XRPUSD
bigtalan bigtalan 6 minutes ago
Yes the increase is on one of my accounts that holds 11,640,000 share so this increase shot it up. My avg is.00114 , just wish I was able to buy when it went into EM but I am fine with the 15m I currently have . GLTA
Symbol Change $ Change % Qty # Price Paid $ Day's Gain $ Total Gain $ Total
RSPI
kBletsgo30 kBletsgo30 6 minutes ago
I wish I had that money damn it!
RSPI
fuagf fuagf 7 minutes ago
Trump's 'loving' phrases: Gonna work with farmers, applause. Gonna get energy down 50%, applause. The border people coming in are destroying us, no applause because no the audience is asking the questions .. https://www.foxnews.com/video/6362046188112 .

Multi lies misinformation
3331 3331 7 minutes ago
BIEL (Bioelectronics):
5 FDA clearances.
https://recoveryrx.carrd.co/
Standard of Care potential for every adult and pet on the planet.
bigtalan bigtalan 8 minutes ago
Yes the increase is on one of my accounts that holds 11,640,000 share so this increase shot it up. My avg is.00114 , just which I was able to buy when it went into EM but I am fine with the 15m I currently have . GLTA
RSPI
northam43 northam43 8 minutes ago
Report #1 Status Report

https://investorshub.advfn.com/uimage/uploads/2024/9/18/nmozh1_Status_Report.PNG
3331 3331 8 minutes ago
BIEL (Bioelectronics):
5 FDA clearances.
https://recoveryrx.carrd.co/
Standard of Care potential for every adult and pet on the planet.
bb8675309 bb8675309 8 minutes ago
Tupperware, company known for its plastic containers, files for Chapter 11 bankruptcy

https://www.msn.com/en-us/money/companies/tupperware-company-known-for-its-plastic-containers-files-for-chapter-11-bankruptcy/ar-AA1qMbEP?ocid=BingNewsSerp
AVXL
ihorchu ihorchu 10 minutes ago
What more could anyone ask for???
NNRX
The Night Stalker The Night Stalker 10 minutes ago
volume increasing week by week. momo will continue until it happens ' within coming days'

in a trip 'within final stages ' of a merger........... gotta be close also right
AZRH
mzasif mzasif 10 minutes ago
Everyone! Hold your shares very tight....3 months are almost up.
DELEX take over any day now..can happen between now, September (3 months) and December (6 months).
Per July 2nd merger announcement ,
All management, operations, and expansion plans will be fully transferred and
BNCM
QaB2i QaB2i 11 minutes ago
??????
VHAI
Newly2b Newly2b 11 minutes ago
No, it sure doesn't make sense that MS would bundle their updates with another company's antivirus, but I have no other explanation since the MS updates were done on September 9th the same date the RAV antivirus showed as downloaded and I have not downloaded anything other than those MS updates or c
LuckyLovie LuckyLovie 11 minutes ago
Nice post,I for 1 could care less if it don't go to 4 but $1 would make my eyes twinkle $ 💰signs...that's why you gotta have a big Lott cause it only gets better the more lotto tixs u have...

Hey there's really not that much in the ANEMIC OTC that could fly high as this 1 coul
IGPK
1Bigmac 1Bigmac 12 minutes ago
Share Count Showdown: https://mmtlpresources.com/
MMATQ
peanutz peanutz 12 minutes ago
From this ?
RSPI

Your Recent History

NASDAQ
ANEB
Anebulo Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved